Precision NanoSystems’ CEO and Co-Founder, James Taylor, is Chosen as One of Business in Vancouver’s 2013/14 Top 40 Under 40

Press Release

May 15, 2014

Vancouver, BC, Canada

Every year, Business in Vancouver recognizes outstanding managers, executives and entrepreneurs in the public, private and non-profit sectors. Winners are chosen by a panel of 5 judges from the Vancouver business community and are celebrated at a gala event in late January, 2014. Precision NanoSystems’ (PNI) CEO and co-founder James Taylor is proud to have been selected as part of this prestigious list. Dr. Taylor notes, “I am happy to be included among this outstanding group of individuals. This recognition is indicative of how quickly Precision NanoSystems has grown and I must credit the entire team for our success.”

Winners were featured in one-on-one interviews on CBC News Vancouver and CBC RadioOne where Dr. Taylor’s excellence in business judgment and leadership were highlighted as they pertained to PNI’s immersion into the rapidly growing nanomedicine industry.

About Precision NanoSystems, Inc.

At Precision NanoSystems we are creating innovative tools for the development and manufacture of best-in-class nanoparticles for use as medicines, and in medical research. Our proprietary NanoAssemblr platform enables the simple, rapid, reproducible, and scalable manufacture of next-generation nanoparticle formulations for the targeted delivery of therapeutic and diagnostic agents to difficult-to-access cells and tissues in the body. We provide instruments, reagents and services to life sciences researchers and build strategic collaborations to revolutionize healthcare through nanotechnology. To join the revolution visit our website.


IN THE NEWS

Press Release

Precision NanoSystems (PNI) is excited to be participating in this year’s SfN conference, Nov. 15th to 19th in Washington, DC. The Walter E. Washington Convention Center will play host to over 30,000 d...

Read More


News Article

The commercial availability of microfluidic platforms aimed specifically at drug formulation is helping to lower the barriers to nanomedicine research. Implementation of this technology eliminates the need for in-house microfluidics expertise and e...

Read More